BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
Sign in
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

Kyndi

Kyndi logo

Website
https://kyndi.com/
Founded
2014

Technologies

AI Companies (Drug Discovery)

Kyndi is an artificial intelligence company that’s building the first Explainable AI platform for government, financial services, and healthcare. Our product exists because critical organizations cannot use “black box” machine learning when they are required to explain the reason for any decision. With its mission to optimize human cognitive performance, Kyndi is transforming business processes by offering auditable AI systems. Kyndi’s products and solutions also help to mitigate the human bias that can arise in the process of extracting knowledge and answers from data.

R&D Platform

The Kyndi Reading Automation Platform is an AI-powered REST API solution that enables enterprise developers to build productivity-enhancing applications that automatically read and comprehend large quantities of documents and allow users to quickly extract insights and information.
Kyndi’s platform does all the hard work of understanding and interpreting text information dramatically faster than humans can read. And unlike other AI software, Kyndi works out of the box with zero training, so you can get up and running immediately.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.